Michael Platten

41.8k total citations · 7 hit papers
300 papers, 15.7k citations indexed

About

Michael Platten is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Michael Platten has authored 300 papers receiving a total of 15.7k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Genetics, 77 papers in Molecular Biology and 75 papers in Oncology. Recurrent topics in Michael Platten's work include Glioma Diagnosis and Treatment (116 papers), Tryptophan and brain disorders (36 papers) and Immunotherapy and Immune Responses (33 papers). Michael Platten is often cited by papers focused on Glioma Diagnosis and Treatment (116 papers), Tryptophan and brain disorders (36 papers) and Immunotherapy and Immune Responses (33 papers). Michael Platten collaborates with scholars based in Germany, United States and Switzerland. Michael Platten's co-authors include Wolfgang Wick, Michael Weller, Christiane A. Opitz, Andreas von Deimling, Felix Sahm, Francesca Fallarino, Ute F. Röhrig, Ellen A. A. Nollen, Benoı̂t J. Van den Eynde and Ulrike Litzenburger and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Michael Platten

290 papers receiving 15.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

2011 1.4k citations Christiane A. Opitz, Felix Sahm et al. profile →
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond

2019 1.1k citations Michael Platten, Christiane A. Opitz et al. profile →
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

2012 769 citations Wolfgang Wick, Michael Platten et al. profile →
Tryptophan Catabolism in Cancer: Beyond IDO and Tryptophan Depletion

2012 554 citations Michael Platten, Wolfgang Wick et al. Cancer Research profile →
MGMT testing—the challenges for biomarker-based glioma treatment

2014 393 citations Wolfgang Wick, Michael Weller et al. profile →
Cancer neuroscience: State of the field, emerging directions

2023 243 citations Michael Platten, Wolfgang Wick et al. profile →
The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients

2023 131 citations Mirco Friedrich, Paola Neri et al. Cancer Cell profile →

Peers

Countries citing papers authored by Michael Platten

Since Specialization

Citations

This map shows the geographic impact of Michael Platten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Platten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Platten more than expected).

Fields of papers citing papers by Michael Platten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Platten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Platten. The network helps show where Michael Platten may publish in the future.

Co-authorship network of co-authors of Michael Platten

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Platten. A scholar is included among the top collaborators of Michael Platten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Platten. Michael Platten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Machine learning-based forecasting of daily acute ischemic stroke admissions using weather data 2025 ·npj Digital Medicine ·(unknown), Kim Eun Hee, David Rügamer, Andreas Bender, Stefan Muthers, (unknown), Angelika Alonso, Kristina Szabo, (unknown), Holger Wenz, Thomas Ganslandt, Michael Platten, Christoph Groden, Michael Neumaier, Fabian Siegel, Máté E. Maros	1
2	The immunology of brain tumors 2025 ·Science Immunology ·Lukas Bunse, Theresa Bunse, Michael Kilian, Francisco J. Quintana, Michael Platten	1
3	optiPRM: A Targeted Immunopeptidomics LC-MS Workflow With Ultra-High Sensitivity for the Detection of Mutation-Derived Tumor Neoepitopes From Limited Input Material 2024 ·Molecular & Cellular Proteomics ·Mogjiborahman Salek, (unknown), Jonas P. Becker, (unknown), Pornpimol Charoentong, (unknown), Katharina A.M. Lindner, (unknown), Michael Volkmar, Frank Momburg, Isabel Poschke, Stefan Fröhling, Marc Schmitz, Rienk Offringa, Michael Platten, Dirk Jäger, Inka Zörnig, Angelika B. Riemer	5
4	The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients breakdown → 2023 ·Cancer Cell ·Mirco Friedrich, Paola Neri, (unknown), (unknown), Simon Steiger, Michael Kilian, Noémie Leblay, Ranjan Maity, Roman Sankowski, (unknown), Elie Barakat, Sungwoo Ahn, Niels Weinhold, Karsten Rippe, Lukas Bunse, Michael Platten, Hartmut Goldschmidt, Carsten Müller‐Tidow, Marc‐Steffen Raab, Nizar J. Bahlis	131
5	Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial 2023 ·Clinical Cancer Research ·Tobias Keßler, Daniel Schrimpf, (unknown), (unknown), Leon D. Kaulen, (unknown), Martin J. van den Bent, Martin Taphoorn, Alba A. Brandes, Ahmed Idbaïh, Julien Dômont, Paul M. Clément, Mario Campone, Martin Bendszus, Andreas von Deimling, Felix Sahm, Michael Platten, Wolfgang Wick, Antje Wick	11
6	Liver sinusoidal endothelial cells orchestrate NK cell recruitment and activation in acute inflammatory liver injury 2023 ·Cell Reports ·(unknown), (unknown), Mingeum Jeong, Carolina De La Torre, Volker Ast, Philipp‐Sebastian Koch, (unknown), Carolin Mogler, Michael Platten, Adelheid Cerwenka, Ana Stojanovic	19
7	Vaccines Targeting Gliomas: Antigens Matter 2023 ·Journal of Clinical Oncology ·Michael Platten, Niklas Graßl	4
8	Targeting of Scavenger Receptors Stabilin-1 and Stabilin-2 Ameliorates Atherosclerosis by a Plasma Proteome Switch Mediating Monocyte/Macrophage Suppression 2022 ·Circulation ·(unknown), Thomas Leibing, Mirco Friedrich, Hendrik Nolte, (unknown), Kai Schledzewski, (unknown), (unknown), Christian David Schmid, (unknown), Ana Stojanovic, Sarah Tonack, Carolina De La Torre, Seddik Hammad, Stefan Offermanns, Marcus Krüger, Adelheid Cerwenka, Michael Platten, Sergij Goerdt, Cyrill Géraud	41
9	A Set of Cell Lines Derived from a Genetic Murine Glioblastoma Model Recapitulates Molecular and Morphological Characteristics of Human Tumors 2021 ·Cancers ·Barbara Costa, Michael Fletcher, (unknown), Ekaterina Ivanova, Tanja Eisemann, (unknown), Lukas Bunse, Martin Löwer, (unknown), Andrey Korshunov, Nadia Coltella, Melania Cusimano, Luigi Naldini, Hai‐Kun Liu, Michael Platten, Bernhard Radlwimmer, Peter Angel, Heike Peterziel	15
10	Intrathecal activation of CD8 ⁺ memory T cells in IgG4‐related disease of the brain parenchyma 2021 ·EMBO Molecular Medicine ·Mirco Friedrich, (unknown), (unknown), (unknown), Katharina A.M. Lindner, (unknown), Iris Mildenberger, Christoph Groden, Achim Gass, Nima Etminan, Marc Fatar, Andreas von Deimling, David Reuß, Michael Platten, Lukas Bunse	8
11	Validation of diffusion MRI phenotypes for predicting response to bevacizumab in recurrent glioblastoma: post-hoc analysis of the EORTC-26101 trial 2020 ·Neuro-Oncology ·Marianne Schell, (unknown), Gianluca Brugnara, Fabian Isensee, Ulf Neuberger, Martha Foltyn, Tobias Keßler, Felix Sahm, Antje Wick, Martha Nowosielski, Sabine Heiland, Michael Weller, Michael Platten, Klaus Maier‐Hein, Andreas von Deimling, Martin J. van den Bent, Thierry Gorlia, Wolfgang Wick, Martin Bendszus, Philipp Kickingereder	9
12	Targeting Resistance against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib 2018 ·Clinical Cancer Research ·Anne Berberich, Tobias Keßler, Carina M. Thomé, Stefan Pusch, Thomas Hielscher, Felix Sahm, Iris Oezen, (unknown), (unknown), (unknown), (unknown), Manuel Fischer, Dieter Lemke, Michael O. Breckwoldt, Andreas von Deimling, Martin Bendszus, Michael Platten, Wolfgang Wick	50
13	Upregulation of tryptophanyl-tRNA synthethase adapts human cancer cells to nutritional stress caused by tryptophan degradation 2018 ·OncoImmunology ·(unknown), Dyah Laksmi Dewi, (unknown), Ahmed Sadik, Soumya R. Mohapatra, Bianca Berdel, Melanie Keil, Jana K. Sonner, Kathrin Thedieck, Adam J. Rose, Michael Platten, Ines Heiland, Saskia Trump, Christiane A. Opitz	45
14	K27M-mutant histone-3 as a novel target for glioma immunotherapy 2017 ·OncoImmunology ·Katharina Ochs, Martina Ott, Theresa Bunse, Felix Sahm, Lukas Bunse, Katrin Deumelandt, Jana K. Sonner, Melanie Keil, Andreas von Deimling, Wolfgang Wick, Michael Platten	89
15	A Phase II, Randomized, Study of Weekly APG101+Reirradiation versus Reirradiation in Progressive Glioblastoma 2014 ·Clinical Cancer Research ·Wolfgang Wick, Harald Fricke, Klaus Junge, (unknown), Tobias Martens, Oliver Heese, Benedikt Wiestler, Maximilian G. Schliesser, Andreas von Deimling, Josef Pichler, (unknown), Inga Harting, Jürgen Debus, Christian Hartmann, (unknown), Michael Platten, Martin Bendszus, Stephanie E. Combs	95
16	The Endogenous Tryptophan Metabolite and NAD+ Precursor Quinolinic Acid Confers Resistance of Gliomas to Oxidative Stress 2013 ·Cancer Research ·Felix Sahm, Iris Oezen, Christiane A. Opitz, Bernhard Radlwimmer, Andreas von Deimling, Tilman Ahrendt, Seray Adams, Helge B. Bode, Gilles J. Guillemin, Wolfgang Wick, Michael Platten	131
17	Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation 2013 ·Neurology ·Wolfgang Wick, Christoph Meisner, Bettina Hentschel, Michael Platten, (unknown), Benedikt Wiestler, Michael Sabel, Susanne Koeppen, Ralf Ketter, Markus Weiler, Ghazaleh Tabatabai, Andreas von Deimling, Dorothee Gramatzki, Manfred Westphal, Gabriele Schackert, Markus Loeffler, Matthias Simon, Guido Reifenberger, Michael Weller	173
18	Costimulatory Protein 4IgB7H3 Drives the Malignant Phenotype of Glioblastoma by Mediating Immune Escape and Invasiveness 2011 ·Clinical Cancer Research ·Dieter Lemke, (unknown), Felix Sahm, (unknown), Tore Kempf, Uwe Warnken, Martina Schnölzer, Ruxandra Tudoran, Michael Weller, Michael Platten, Wolfgang Wick	118
19	Treatment of Autoimmune Neuroinflammation with a Synthetic Tryptophan Metabolite 2005 ·Science ·Michael Platten, Peggy P. Ho, Sawsan Youssef, Paulo Fontoura, Hideki Garren, Eun Mi Hur, Rohit Gupta, Lowen Y. Lee, Brian Kidd, William H. Robinson, Raymond A. Sobel, Michael L. Selley, Lawrence Steinman	350
20	Malignant glioma biology: Role for TGF-? in growth, motility, angiogenesis, and immune escape 2001 ·Microscopy Research and Technique ·Michael Platten, Wolfgang Wick, Michael Weller	201

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact